Skip to Main Content
 

Global Search Box

 
 
 
 

ETD Abstract Container

Abstract Header

Formulation and In-vitro Evaluation of FDM 3D Printed Tablet with different Drug Loading

Abstract Details

2021, Master of Science in Pharmaceutical Science (MSP), University of Toledo, Pharmaceutical Sciences (Industrial Pharmacy).
Patient-specific medicine is a growing area of treatment in the healthcare sector and additive manufacturing, or 3D printing technology is a recent pharmaceutical approach to confront the challenge of this individualized drug delivery system. The focus of this study was to investigate the feasibility of formulating a 3D printed personalized dosage form using fused deposition modelling (FDM) in combination with hot-melt extrusion (HME) process. Acetaminophen was selected as a model drug and a commercial polyvinyl alcohol (PVA) filament was used to fabricate 3D printed tablets with two different drug loading percentages. After screening several polyvinyl alcohols (PVA), the commercial PVA filament was selected to enhance the extrusion process. 5% and 15% acetaminophen loaded filaments were successfully extruded through a filament extruder and tablets were printed using an FDM 3D printer. Thermal analysis using DSC and TGA confirmed the thermal stability of 3D printed tablets. No endothermic events corresponding to acetaminophen were observed in the DSC thermograms of drug-loaded filaments and tablets indicating that the drug was amorphously dispersed in PVA. With TGA, the drug-loaded filaments and tablets did not show any appreciable weight loss at the printing temperature of 240 ˚C suggesting that the polymer was stabilizing the drug. Molecular interactions of acetaminophen and PVA on drug-loaded tablets were verified through FTIR analysis. SEM micrographs of cross-sectioned drug-loaded filaments appeared to have a rough surface in compare to the commercial PVA filament due to the inclusion of acetaminophen, which was consistent with the drug-loaded tablets as well. Physical and mechanical characterization was performed according to mandated standards. The 3D printed tablets passed the weight variation, friability, thickness, dimensions, and breaking force tests with minimal outliers. Drug content loss was analyzed using a validated HPLC method. HPLC data demonstrated that increasing the temperature during the filament extrusion and FDM 3D printing process caused a measurable amount of drug loss. The prolonged disintegration time of the tablets suggested that FDM 3D printed tablets would be a considerable design for zero-order release formulation. The cylinder shape tablets exhibited higher disintegration time compared to the capsule shape with the same surface area, indicating an influence of geometrical shape on the drug release profile. The outcome of this project can mark a footprint of a revolutionary technology in the pharmaceutical industry that can facilitate the personalization of the drug delivery system.
Jerry Nesamony (Committee Chair)
Joseph Lawrence (Committee Member)
Gabriella Baki (Committee Member)
69 p.

Recommended Citations

Citations

  • Subah, F. N. (2021). Formulation and In-vitro Evaluation of FDM 3D Printed Tablet with different Drug Loading [Master's thesis, University of Toledo]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=mco1620409711278343

    APA Style (7th edition)

  • Subah, Farhana Noor. Formulation and In-vitro Evaluation of FDM 3D Printed Tablet with different Drug Loading. 2021. University of Toledo, Master's thesis. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=mco1620409711278343.

    MLA Style (8th edition)

  • Subah, Farhana Noor. "Formulation and In-vitro Evaluation of FDM 3D Printed Tablet with different Drug Loading." Master's thesis, University of Toledo, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=mco1620409711278343

    Chicago Manual of Style (17th edition)